Vancouver-based UPGUYS is making waves in the Canadian healthtech scene, with its founders recently named finalists for the EY Entrepreneur Of The Year 2026 Pacific Region program. This recognition highlights the company’s unique growth trajectory—achieving nationwide scale without outside funding, a rarity in the highly regulated healthcare industry.
### What UPGUYS Actually Does
UPGUYS, co-founded by Ramin Behzadi and pharmacist Mat Rezaei in 2019, is a comprehensive healthcare platform. It primarily focuses on men’s health but plans to expand into hormone health, preventative care, and longevity. Its model integrates digital accessibility with clinical oversight, providing pharmacy services and continuous patient care. Through this approach, UPGUYS has managed to serve tens of thousands of patients across Canada, facilitated by a robust team of licensed practitioners, pharmacy infrastructure, and lab testing capabilities.
The company employs a workforce of around 70, with 80% based in British Columbia, underscoring Vancouver’s role as a hub for its operations and talent acquisition. This strategic choice has allowed UPGUYS to maintain a consistent patient experience while navigating the complex regulatory landscape of Canadian healthcare.
### Competitive Context
In the competitive landscape of Canadian healthtech, UPGUYS stands out for its founder-funded model. Unlike many startups that rely heavily on venture capital to fuel growth, UPGUYS has scaled through personal investment, with Behzadi investing approximately $1.2 million at the outset. This approach has required operational discipline and a focus on building solid infrastructure, differentiating UPGUYS from peers who might prioritize rapid scaling through external funding.
The healthcare sector in Canada is notoriously difficult to penetrate due to stringent regulations and provincial variations. UPGUYS has managed to navigate these challenges, positioning itself as a significant player in digital health without succumbing to the pressures of external capital. This could potentially set a new precedent for how healthtech companies approach growth and funding.
### Real Implications for Industry Stakeholders
For founders and engineers in the healthtech space, UPGUYS offers a case study in disciplined growth and the potential of founder funding. The company’s path demonstrates that with the right infrastructure and focus, it’s possible to scale nationally even in a regulated industry. This might inspire other entrepreneurs to reconsider dependency on venture capital, especially when building platforms that require regulatory compliance and operational robustness.
For investors, UPGUYS’ success without external funding might challenge the typical investment thesis in healthtech. It suggests that there might be untapped potential in founder-led companies that prioritize sustainable growth over immediate scale.
### What Happens Next
Looking ahead, UPGUYS plans to broaden its service offerings, moving beyond men’s health to encompass a wider range of healthcare services. This expansion will likely involve hiring more practitioners, pharmacists, and developers to support the company’s growth ambitions. The EY recognition is a milestone, but the real challenge will be maintaining its growth trajectory while ensuring compliance and quality care across Canada.
For founders in regulated industries, UPGUYS’ story is a reminder that growth can be achieved without conforming to the typical venture-backed model. It underscores the importance of infrastructure and compliance, offering a blueprint for building sustainable, scalable businesses.
